• Prosigna Breast Cancer Prognostic Gene Signature
  • Phenobarbital, Urine
  • Haloperidol, Urine
  • Galactose, Quantitative, Plasma
  • Alpha-L-Iduronidase (IDUA) Genetic Mutation Analysis
  • Growth Hormone Releasing Hormone
  • Class of Anticonvulsants
  • Beta-Glucosidase, Fibroblasts
  • Hepatitis Be Antigen
  • Semen Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
Medical Test

Diseases (1)
Access to Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants is restricted.